ARROWHEAD PHARMACEUTICALS, INC.

SEC 4 · Filed

0001830755-26-000002Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Jan 5, 2026

Sale by Hamilton James C

Security
Common Stock
Code
S
Shares
309
Price per share
68.00
Structured facts
{
  "code": "S",
  "date": "2026-01-05",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Shares were sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.",
    "F2": "Partial disposition of shares to satisfy tax withholding obligations.",
    "F4": "Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person, a portion of which are still subject to certain vesting conditions."
  },
  "owners": [
    {
      "cik": "0001830755",
      "name": "Hamilton James C",
      "roles": [
        "officer"
      ],
      "title": "Chief Medical Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "171958",
  "price": "68",
  "row": 7,
  "rule_10b5_1": "1",
  "security": "Common Stock",
  "shares": "309",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date Jan 5, 2026

Sale by Hamilton James C

Security
Common Stock
Code
S
Shares
437
Price per share
65.97
Structured facts
{
  "code": "S",
  "date": "2026-01-05",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Shares were sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.",
    "F2": "Partial disposition of shares to satisfy tax withholding obligations.",
    "F4": "Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person, a portion of which are still subject to certain vesting conditions.",
    "F9": "The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $65.90 to $66.12, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."
  },
  "owners": [
    {
      "cik": "0001830755",
      "name": "Hamilton James C",
      "roles": [
        "officer"
      ],
      "title": "Chief Medical Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "172267",
  "price": "65.97",
  "row": 6,
  "rule_10b5_1": "1",
  "security": "Common Stock",
  "shares": "437",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date Jan 5, 2026

Sale by Hamilton James C

Security
Common Stock
Code
S
Shares
1,200
Price per share
64.49
Structured facts
{
  "code": "S",
  "date": "2026-01-05",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Shares were sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.",
    "F2": "Partial disposition of shares to satisfy tax withholding obligations.",
    "F4": "Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person, a portion of which are still subject to certain vesting conditions.",
    "F8": "The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $64.44 to $64.70, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."
  },
  "owners": [
    {
      "cik": "0001830755",
      "name": "Hamilton James C",
      "roles": [
        "officer"
      ],
      "title": "Chief Medical Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "172704",
  "price": "64.49",
  "row": 5,
  "rule_10b5_1": "1",
  "security": "Common Stock",
  "shares": "1200",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date Jan 5, 2026

Sale by Hamilton James C

Security
Common Stock
Code
S
Shares
12,711
Price per share
63.95
Structured facts
{
  "code": "S",
  "date": "2026-01-05",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Shares were sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.",
    "F2": "Partial disposition of shares to satisfy tax withholding obligations.",
    "F4": "Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person, a portion of which are still subject to certain vesting conditions.",
    "F7": "The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $63.57 to $64.41, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."
  },
  "owners": [
    {
      "cik": "0001830755",
      "name": "Hamilton James C",
      "roles": [
        "officer"
      ],
      "title": "Chief Medical Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "173904",
  "price": "63.95",
  "row": 4,
  "rule_10b5_1": "1",
  "security": "Common Stock",
  "shares": "12711",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date Jan 5, 2026

Sale by Hamilton James C

Security
Common Stock
Code
S
Shares
14,792
Price per share
63.01
Structured facts
{
  "code": "S",
  "date": "2026-01-05",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Shares were sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.",
    "F2": "Partial disposition of shares to satisfy tax withholding obligations.",
    "F4": "Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person, a portion of which are still subject to certain vesting conditions.",
    "F6": "The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $62.61 to $63.56, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."
  },
  "owners": [
    {
      "cik": "0001830755",
      "name": "Hamilton James C",
      "roles": [
        "officer"
      ],
      "title": "Chief Medical Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "186615",
  "price": "63.01",
  "row": 3,
  "rule_10b5_1": "1",
  "security": "Common Stock",
  "shares": "14792",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date Jan 5, 2026

Sale by Hamilton James C

Security
Common Stock
Code
S
Shares
6,090
Price per share
62.28
Structured facts
{
  "code": "S",
  "date": "2026-01-05",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Shares were sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.",
    "F2": "Partial disposition of shares to satisfy tax withholding obligations.",
    "F4": "Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person, a portion of which are still subject to certain vesting conditions.",
    "F5": "The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $61.84 to $62.60, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."
  },
  "owners": [
    {
      "cik": "0001830755",
      "name": "Hamilton James C",
      "roles": [
        "officer"
      ],
      "title": "Chief Medical Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "201407",
  "price": "62.28",
  "row": 2,
  "rule_10b5_1": "1",
  "security": "Common Stock",
  "shares": "6090",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date Jan 5, 2026

Sale by Hamilton James C

Security
Common Stock
Code
S
Shares
4,625
Price per share
61.24
Structured facts
{
  "code": "S",
  "date": "2026-01-05",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Shares were sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.",
    "F2": "Partial disposition of shares to satisfy tax withholding obligations.",
    "F3": "The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $60.80 to $61.66, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4.",
    "F4": "Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person, a portion of which are still subject to certain vesting conditions."
  },
  "owners": [
    {
      "cik": "0001830755",
      "name": "Hamilton James C",
      "roles": [
        "officer"
      ],
      "title": "Chief Medical Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "207497",
  "price": "61.24",
  "row": 1,
  "rule_10b5_1": "1",
  "security": "Common Stock",
  "shares": "4625",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}